Fig 1.
Representative images of suboptimal findings detected on optical coherence tomography.
(A) Tissue protrusion (white arrows). Maximal length (white two-way arrows) and area (red line) of tissue protrusion. (B) Edge dissection (white arrow). Maximal flap opening (yellow two-way arrow), maximal length (white two-way arrow) and arc (blue line) of edge dissection. (C) Malapposition (white arrows). Lumen area (yellow broken line), stent area (red broken line) and maximal depth (white two-way arrow) of malapposition. Malapposition area was calculated by subtracting stent area from lumen area. (D) Thrombus (white arrow). Diameter (red two-way arrow) of thrombus.
Fig 2.
PCI: percutaneous coronary intervention DES: drug-eluting stent; OCT: optical coherence tomography; CAG: coronary angiography; SF-OCT: optical coherence tomography detected suboptimal findings.
Table 1.
Baseline patient characteristics.
Table 2.
Angiographic and procedural data.
Fig 3.
Incidences of suboptimal findings detected by optical coherence tomography (OCT).
(A) Incidence of each component. (B) Cumulative incidence of suboptimal optical coherence tomography-detected findings.
Table 3.
Quantification data of suboptimal optical coherence tomography-detected findings.
Table 4.
Predictors of suboptimal findings detected by optical coherence tomography.
Fig 4.
Survival free of major adverse cardiovascular events according to optical coherence tomography-detected poststent optimal versus suboptimal findings.
Table 5.
Clinical outcomes.
Table 6.
Predictors of major adverse cardiovascular events.